As of 2025-05-16, the Relative Valuation of China Health Group Ltd (673.HK) is (1.02) HKD. This relative valuation is based on P/E multiples. With the latest stock price at 0.14 HKD, the upside of China Health Group Ltd based on Relative Valuation is -827.3%.
The range of the Relative Valuation is (1.13) - (0.96) HKD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 11.1x | 9.4x |
| Forward P/E multiples | 13.1x - 15.4x | 14.1x |
| Fair Price | (1.13) - (0.96) | (1.02) |
| Upside | -909.1% - -785.6% | -827.3% |
| Date | P/E |
| 2025-05-02 | -1.62 |
| 2025-04-30 | -1.62 |
| 2025-04-29 | -1.68 |
| 2025-04-28 | -1.71 |
| 2025-04-25 | -1.97 |
| 2025-04-24 | -1.68 |
| 2025-04-23 | -2.17 |
| 2025-04-22 | -2.31 |
| 2025-04-17 | -2.09 |
| 2025-04-16 | -2.09 |
| 2025-04-15 | -2.09 |
| 2025-04-14 | -2.09 |
| 2025-04-11 | -2.20 |
| 2025-04-10 | -2.26 |
| 2025-04-09 | -2.31 |
| 2025-04-08 | -2.31 |
| 2025-04-07 | -2.32 |
| 2025-04-03 | -2.80 |
| 2025-04-02 | -2.73 |
| 2025-04-01 | -2.73 |
| 2025-03-31 | -2.74 |
| 2025-03-28 | -2.74 |
| 2025-03-27 | -2.78 |
| 2025-03-26 | -2.87 |
| 2025-03-25 | -2.56 |
| 2025-03-24 | -2.72 |
| 2025-03-21 | -2.76 |
| 2025-03-20 | -2.72 |
| 2025-03-19 | -2.87 |
| 2025-03-18 | -2.43 |
| 2025-03-17 | -2.30 |
| 2025-03-14 | -2.27 |
| 2025-03-13 | -2.27 |
| 2025-03-12 | -2.24 |
| 2025-03-11 | -2.13 |
| 2025-03-10 | -1.93 |
| 2025-03-07 | -2.17 |
| 2025-03-06 | -2.29 |
| 2025-03-05 | -2.28 |
| 2025-03-04 | -2.29 |
| 2025-03-03 | -2.31 |
| 2025-02-28 | -2.26 |
| 2025-02-27 | -2.29 |
| 2025-02-26 | -2.51 |
| 2025-02-25 | -2.61 |
| 2025-02-24 | -2.75 |
| 2025-02-21 | -2.88 |
| 2025-02-20 | -2.88 |
| 2025-02-19 | -2.89 |
| 2025-02-18 | -2.83 |